MarketInOut Stock Screener Log In | Sign Up
 

Sanofi S.A.

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 05/07/2026 14:55
Sanofi S.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization90,218 mln
Float1,087 mln
Earnings Date04/23/2026

EPS

3.96
Solid

P / E

18.65
Moderately valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.45
Borderline

Relative Strength

3 / 100
Severely lagging

Debt / Equity

0.28
Very low leverage

Business Description

Sanofi is a Paris-based global pharmaceutical company founded in 1994 that develops, manufactures, and sells treatments across a wide range of medical areas, including rare diseases, cancer, neurology, and immune conditions, as well as vaccines for diseases such as hepatitis, rabies, and yellow fever. The company works with numerous partners to advance next-generation therapies, including AI-driven drug discovery, protein degradation treatments, genome editing, and antibody-based medicines. Through these collaborations, Sanofi aims to bring innovative solutions to patients dealing with some of the most complex and difficult-to-treat conditions.

Key Fundamentals

EPS3.96
P/E18.65
ROE10.71
RPS38.04
ROIC7.04
ROA6.09
Interest Cover15.33
EBITDA, mln12,479
EV / EBITDA8.87
EV / EBIT16.28
Revenue, mln46,716
EV / Revenue2.37

Financial Strength

Altman Z-Score1.61
Piotroski F-Score 7 / 9
Beneish M-Score-2.45
Price to Intrinsic Value0.74
Price to Graham Number3.54
Shiller PE Ratio12.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.92% 2 / 100   
1 Month -8.57% 4 / 100   
2 Months -5.34% 18 / 100   
6 Months -16.09% 10 / 100   
1 Year -16.38% 11 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us